New registry aims to uncover dengue risks for bleeding disorder patients
NCT ID NCT07409857
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study creates a registry to collect data on dengue infections in people with congenital bleeding disorders like hemophilia. Dengue can cause serious bleeding, and those with bleeding disorders may face higher risks. The goal is to understand bleeding complications, treatment needs, and outcomes to improve care for this vulnerable group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL BLEEDING DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ramathibodi Hospital
RECRUITINGBangkok, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dengue vaccine be both Cost-Effective and trusted? a thai study investigates
- Dengue vaccine booster put to the test: can it shield against all four virus types?
- Flu drug zanamivir tested against Dengue's deadliest complication
- Could a second dose of dengue vaccine boost protection for kids?
- AI toolkit aims to speed up epidemic response for diseases like COVID-19 and mpox
- Could a new vaccine shield infants from dengue?